These trials are enormously expensive, and pharmaceutical companies typically price medications to recoup these investments
In general, the drugs get the green light for women with a body mass index (BMI) of 30 or higher, or for those with a BMI of 25 to 29.9 with certain coexisting conditions (like high blood pressure or diabetes)
Final Thoughts Before making any definitive decisions, ensure you discuss your options with a licensed healthcare professional who can evaluate whether semaglutide is appropriate for you and, if so, help monitor your situation
Our study highlights an unexpected consequence of semaglutide treatment in a preclinical model of juvenile protein malnutrition, suggesting caution is warranted when using GLP-1RAs in low protein-intake infants prone to metabolic disorders
Autophagy 15(3):453465 Hubbard BP, Sinclair DA (2014) Small molecule SIRT1 activators for the treatment of aging and age-related diseases